Author Question: A nurse is reviewing research on the efficacy of telehealth over the past several years. The nurse ... (Read 51 times)

charchew

  • Hero Member
  • *****
  • Posts: 579
A nurse is reviewing research on the efficacy of telehealth over the past several years. The nurse would identify which of the following conditions as having outcomes most significantly affected by the use of telehealth? Select all that apply.
 
  A) Chronic lung disease
  B) Kidney failure
  C) Heart disease
  D) Newborn health
  E) Psychiatric conditions

Question 2

After teaching a group of students about the benefits of telehealth, the instructor determines that the teaching was successful when the students identify which of the following as a benefit?
 
  A) Increased travel time
  B) Increased productivity
  C) Increased face-to-face patient contact
  D) Increased healthcare costs



ankilker

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

C, E

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library